A joint study by Boston Children's Hospital, Harvard University and OpenAI reanalyzed 376 previously unsolved pediatric rare genetic disease cases using OpenAI's reasoning model "o3 Deep Research," leading to 18 new confirmed diagnoses, according to a paper published in NEJM AI on June 18, 2026. Led by Boston Children's Hospital's Manton Center for Orphan Disease Research, the paper is titled "LLM-Assisted Reanalysis of Unsolved Rare Disease Genomes Increases Diagnostic Yield." The additional diagnostic yield was 4.8%.
Continue reading
The rest of this article is for AI News Blitz readers. Choose an option below to keep reading.
Already purchased? Sign in✓ Signed in — this article isn’t included in your current plan.
Unlocking the full article...
Contact us
Questions, corrections, or ideas? Send us a message here. We aim to reply by email within 24 hours.
Thank you. Your message has been sent. We aim to reply by email within 24 hours.Please enter your email address and a message.We could not send your message. Please try again in a little while.